Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

How long does it take to complete outpatient substance use disorder treatment? Disparities among Blacks, Hispanics, and Whites in the US.

Mennis J, Stahler GJ, El Magd SA, Baron DA.

Addict Behav. 2019 Jun;93:158-165. doi: 10.1016/j.addbeh.2019.01.041. Epub 2019 Jan 28.

PMID:
30711669
2.

Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Kovacs G, Dumitrescu D, Barner A, Greiner S, Grünig E, Hager A, Köhler T, Kozlik-Feldmann R, Kruck I, Lammers AE, Mereles D, Meyer A, Meyer J, Pabst S, Seyfarth HJ, Sinning C, Sorichter S, Stähler G, Wilkens H, Held M.

Int J Cardiol. 2018 Dec 1;272S:11-19. doi: 10.1016/j.ijcard.2018.08.083. Epub 2018 Aug 27. Review.

PMID:
30219257
3.

Treatment outcome disparities for opioid users: Are there racial and ethnic differences in treatment completion across large US metropolitan areas?

Stahler GJ, Mennis J.

Drug Alcohol Depend. 2018 Sep 1;190:170-178. doi: 10.1016/j.drugalcdep.2018.06.006. Epub 2018 Jul 11.

PMID:
30041092
4.

Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.

Halank M, Hoeper MM, Ghofrani HA, Meyer FJ, Stähler G, Behr J, Ewert R, Fletcher M, Colorado P, Nikkho S, Grimminger F.

Respir Med. 2017 Jul;128:50-56. doi: 10.1016/j.rmed.2017.05.008. Epub 2017 May 16.

5.

[Clinical classification and initial diagnosis of pulmonary hypertension: recommendations of the Cologne Consensus Conference 2016].

Kovacs G, Dumitrescu D, Barner A, Greiner S, Grünig E, Hager A, Köhler T, Kozlik-Feldmann R, Kruck I, Lammers A, Mereles D, Meyer A, Meyer FJ, Pabst S, Seyfarth HJ, Sinning C, Sorichter S, Stähler G, Wilkens H, Held M.

Dtsch Med Wochenschr. 2016 Oct;141(S 01):S10-S18. Epub 2016 Oct 19. Review. German.

PMID:
27760445
6.

Risky Substance Use Environments and Addiction: A New Frontier for Environmental Justice Research.

Mennis J, Stahler GJ, Mason MJ.

Int J Environ Res Public Health. 2016 Jun 18;13(6). pii: E607. doi: 10.3390/ijerph13060607. Review.

7.

Residential and outpatient treatment completion for substance use disorders in the U.S.: Moderation analysis by demographics and drug of choice.

Stahler GJ, Mennis J, DuCette JP.

Addict Behav. 2016 Jul;58:129-35. doi: 10.1016/j.addbeh.2016.02.030. Epub 2016 Feb 17.

PMID:
26925821
8.

Racial and Ethnic Disparities in Outpatient Substance Use Disorder Treatment Episode Completion for Different Substances.

Mennis J, Stahler GJ.

J Subst Abuse Treat. 2016 Apr;63:25-33. doi: 10.1016/j.jsat.2015.12.007. Epub 2015 Dec 29.

PMID:
26818489
9.

Effects of a strategy to improve offender assessment practices: Staff perceptions of implementation outcomes.

Welsh WN, Lin HJ, Peters RH, Stahler GJ, Lehman WE, Stein LA, Monico L, Eggers M, Abdel-Salam S, Pierce JC, Hunt E, Gallagher C, Frisman LK.

Drug Alcohol Depend. 2015 Jul 1;152:230-8. doi: 10.1016/j.drugalcdep.2015.03.033. Epub 2015 Apr 9.

10.

[Supportive therapy in pulmonary arterial hypertension].

Grünig E, Ehlken N, Hohenforst-Schmidt W, Krüger U, Krüger S, Lichtblau M, Marra AM, Meyer A, Olschewski H, Olsson KM, Stähler G, Sablotzki A, Skowasch D, Wenter C, Kähler C, Ulrich S, Speich R, Lang I, Hoenen S, Meyer FJ, Bonderman D, Stark W, Hoeper MM.

Dtsch Med Wochenschr. 2014 Dec;139 Suppl 4:S136-41. doi: 10.1055/s-0034-1387453. Epub 2014 Dec 9. Review. German. No abstract available.

PMID:
25489683
12.

Geospatial technology and the "exposome": new perspectives on addiction.

Stahler GJ, Mennis J, Baron DA.

Am J Public Health. 2013 Aug;103(8):1354-6. doi: 10.2105/AJPH.2013.301306. Epub 2013 Jun 13.

13.

[Exercise testing in respiratory medicine].

Meyer FJ, Borst MM, Buschmann HC, Ewert R, Friedmann-Bette B, Ochmann U, Petermann W, Preisser AM, Rohde D, Rühle KH, Sorichter S, Stähler G, Westhoff M, Worth H.

Pneumologie. 2013 Jan;67(1):16-34. doi: 10.1055/s-0032-1325901. Epub 2013 Jan 16. German.

14.

Burden of pulmonary arterial hypertension in Germany.

Wilkens H, Grimminger F, Hoeper M, Stähler G, Ehlken B, Plesnila-Frank C, Berger K, Resch A, Ghofrani A.

Respir Med. 2010 Jun;104(6):902-10. doi: 10.1016/j.rmed.2010.01.002. Epub 2010 Feb 9.

15.

The influence of neighborhood environment on treatment continuity and rehospitalization in dually diagnosed patients discharged from acute inpatient care.

Stahler GJ, Mennis J, Cotlar R, Baron DA.

Am J Psychiatry. 2009 Nov;166(11):1258-68. doi: 10.1176/appi.ajp.2009.08111667. Epub 2009 Oct 1.

PMID:
19797433
16.

[Specific drugs for the treatment of pulmonary arterial hypertension - current status].

Stähler G.

Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S183-6. doi: 10.1055/s-0028-1091234. Epub 2008 Sep 23. Review. German.

PMID:
18814092
17.

Flexible robotic retrograde renoscopy: description of novel robotic device and preliminary laboratory experience.

Desai MM, Aron M, Gill IS, Pascal-Haber G, Ukimura O, Kaouk JH, Stahler G, Barbagli F, Carlson C, Moll F.

Urology. 2008 Jul;72(1):42-6. doi: 10.1016/j.urology.2008.01.076. Epub 2008 Apr 18.

PMID:
18372029
18.

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.

King TE Jr, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stähler G, Leconte I, Roux S, Raghu G.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):75-81. Epub 2007 Sep 27.

PMID:
17901413
19.

A faith-based intervention for cocaine-dependent Black women.

Stahler GJ, Kirby KC, Kerwin ME.

J Psychoactive Drugs. 2007 Jun;39(2):183-90.

PMID:
17703713
20.

Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study.

Günther A, Enke B, Markart P, Hammerl P, Morr H, Behr J, Stähler G, Seeger W, Grimminger F, Leconte I, Roux S, Ghofrani HA.

Eur Respir J. 2007 Apr;29(4):713-9. Epub 2007 Jan 10.

21.

The effect of individual, program, and neighborhood variables on continuity of treatment among dually diagnosed individuals.

Stahler GJ, Mazzella S, Mennis J, Chakravorty S, Rengert G, Spiga R.

Drug Alcohol Depend. 2007 Feb 23;87(1):54-62. Epub 2006 Sep 7.

PMID:
16962255
22.

Successful treatment of portopulmonary hypertension with bosentan: case report.

Stähler G, von Hunnius P.

Eur J Clin Invest. 2006 Sep;36 Suppl 3:62-6.

PMID:
16919013
23.

[A role for combination therapy in pulmonary arterial hypertension].

Behr J, Borst MM, Winkler J, Hoeper M, Halank M, Ghofrani A, Klose H, Wilkens H, Stähler G.

Pneumologie. 2005 Oct;59(10):730-5. German.

PMID:
16222588
24.

Development and initial demonstration of a community-based intervention for homeless, cocaine-using, African-American Women.

Stahler GJ, Shipley TE Jr, Kirby KC, Godboldte C, Kerwin ME, Shandler I, Simons L.

J Subst Abuse Treat. 2005 Mar;28(2):171-9.

PMID:
15780547
25.

Using ethnographic methodology in substance abuse treatment outcome research.

Stahler GJ, Cohen E.

J Subst Abuse Treat. 2000 Jan;18(1):1-8.

PMID:
10636600
26.

IORT for locally advanced or recurrent renal cell carcinoma.

Eble MJ, Stähler G, Wannenmacher M.

Front Radiat Ther Oncol. 1997;31:253-5. No abstract available.

PMID:
9263835
27.

Evaluating alternative treatments for homeless substance-abusing men: outcomes and predictors of success.

Stahler GJ, Shipley TF Jr, Bartelt D, DuCette JP, Shandler IW.

J Addict Dis. 1995;14(4):151-67.

PMID:
8929938
28.

Social interventions for homeless substance abusers: evaluating treatment outcomes.

Stahler GJ.

J Addict Dis. 1995;14(4):xv-xxvi. Review. No abstract available.

PMID:
8929929
29.

Evaluating adolescent pregnancy programs: rethinking our priorities.

Stahler GJ, DuCette JP.

Fam Plann Perspect. 1991 May-Jun;23(3):129-33.

PMID:
1860479
30.

The evaluation component in adolescent pregnancy care projects: is it adequate?

Stahler GJ, DuCette J, McBride D.

Fam Plann Perspect. 1989 May-Jun;21(3):123-6. Review. No abstract available.

PMID:
2668021
31.

The factor structure of the Colorado Level of Functioning Measure.

Stahler GJ.

J Clin Psychol. 1987 Nov;43(6):696-8.

PMID:
3693559
32.

Do therapists bias their ratings of patient functioning under peer review?

Stahler GJ, Rappaport H.

Community Ment Health J. 1986 Winter;22(4):265-74.

PMID:
3829602
33.

The evaluation of an environmental remodeling program on a psychiatric geriatric ward.

Stahler GJ, Frazer D, Rappaport H.

J Soc Psychol. 1984 Jun;123(1ST Half):101-13. No abstract available.

PMID:
6482395
34.

Alteration of pressure-volume characteristics due to different types of edema induction in isolated rabbit lungs.

Seeger W, Wolf HR, Stähler G, Neuhof H.

Respiration. 1983;44(4):273-81.

PMID:
6410476
36.

Increased pulmonary vascular resistance and permeability due to arachidonate metabolism in isolated rabbit lungs.

Seeger W, Wolf H, Stähler G, Neuhof H, Róka L.

Prostaglandins. 1982 Feb;23(2):157-73.

PMID:
6805041
37.

Enhancing the utilization of evaluation findings.

Tash WR, Stahler GJ.

Community Ment Health J. 1982 Fall;18(3):180-9. No abstract available.

PMID:
7172614
38.

[Increase of pulmonary vascular resistance and permeability due to the metabolism of free arachidonic acid (author's transl)].

Seeger W, Wolf H, Stähler G, Neuhof H, Róka L.

Klin Wochenschr. 1981 May 4;59(9):459-61. German.

PMID:
7278087
39.

Supplemental Content

Loading ...
Support Center